How are arrhythmias detected by implanted cardiac devices managed in Europe?: Results of the European Heart Rhythm Association Survey
2015 (English)In: Europace, ISSN 1099-5129, E-ISSN 1532-2092, Vol. 17, no 9, 1449-1453 p.Article in journal (Refereed) Published
The management of arrhythmias detected by implantable cardiac devices can be challenging. There are no formal international guidelines to inform decision-making. The purpose of this European Heart Rhythm Association (EHRA) survey was to assess the management of various clinical scenarios among members of the EHRA electrophysiology research network. There were 49 responses to the questionnaire. The survey responses were mainly (81%) from medium-high volume device implanting centres, performing more than 200 total device implants per year. Clinical scenarios were described focusing on four key areas: the implantation of pacemakers for bradyarrhythmia detected on an implantable loop recorder (ILR), the management of patients with ventricular arrhythmia detected by an ILR or pacemaker, the management of atrial fibrillation in patients with pacemakers and cardiac resynchronization therapy devices and the management of ventricular tachycardia in patients with implantable cardioverter-defibrillators.
Place, publisher, year, edition, pages
2015. Vol. 17, no 9, 1449-1453 p.
Implantable loop recorder, Pacemaker, Implantable cardiac-defibrillator, EHRA survey, EP wire
Cardiac and Cardiovascular Systems
IdentifiersURN: urn:nbn:se:uu:diva-265590DOI: 10.1093/europace/euv310ISI: 000362825200018PubMedID: 26443791OAI: oai:DiVA.org:uu-265590DiVA: diva2:866508